Last Updated: June 22, 2026
Ketamine for Burnout: Key Findings From Mindbloom's Data
This article covers Mindbloom's published preprint on ketamine-assisted therapy for burnout, the first real-world outcomes study of its kind, including what the data showed across all three burnout dimensions, how quickly improvement occurred, and what the findings mean for people experiencing sustained exhaustion, cynicism, or reduced efficacy in a demanding role.
.jpg)
Key takeaways
- Of Mindbloom patients with the most severe burnout profile, 76.1% no longer met that classification after completing treatment.
- Meaningful improvement began within the first two sessions and kept building through the sixth session with no plateau.
- Among 395 adults with elevated burnout who completed Mindbloom's at-home ketamine-assisted therapy, 69.6% improved on at least one core burnout subscale.
- Cynicism, the burnout-specific marker that distinguishes burnout from depression, showed a 22% reduction, suggesting the treatment reached beyond mood improvement alone.
- Professional efficacy, the slowest-moving component, improved modestly at 7%, consistent with the idea that rebuilding role-specific confidence requires behavioral change beyond biology alone.
What Burnout Actually Is and Why Rest Doesn't Fix It
The World Health Organization classifies burnout in the ICD-11 as an occupational phenomenon rather than a medical diagnosis. The same pattern of exhaustion, detachment, and eroded efficacy shows up in caregiving, parenting, and other demanding roles.
Researchers have validated parental burnout as a separate but parallel construct.1 Every outcome number in the following sections reflects occupational burnout measured by a validated workplace instrument.
Burnout consists of three dimensions that build in sequence:
- Exhaustion: The tank is empty, and sleep does not refill it.
- Cynicism and emotional distancing: Going through the motions at work or pulling back from loved ones characterizes this stage. Distancing is burnout's signature move and the piece that looks least like depression.
- Reduced professional efficacy: You experience a lingering sense that you are failing at the role that matters most to you.
Burnout and depression genuinely overlap, and the boundary between them remains debated. The research consensus is that they are related but not identical. The most burnout-specific signal is the cynicism and detachment toward the role, which is not a core depression symptom.
Depression is a pervasive, global lowering of mood, while burnout is a role-rooted erosion. Anxiety is activation, characterized by worry, dread, and a body braced for threat. Burnout's exhaustion is almost the opposite, defined by depletion and disengagement rather than alarm.
Understanding the distinction matters. The strong improvement in cynicism provides evidence that something beyond depression lifting was happening.
Rest, vacation, and boundaries are the standard advice for burnout. By the time it becomes true burnout, chronic stress has left a biological footprint. The physical impact includes HPA-axis dysregulation, altered glutamate signaling, and reduced BDNF.
Burnout is not a willpower or scheduling problem, and rest typically does not address what is happening in the brain.
About Mindbloom's Burnout Research
Mindbloom's published analysis of 395 adults, published as a preprint on Research Square (doi.org/10.21203/rs.3.rs-10020276/v1), is the first publicly available outcomes data of ketamine-assisted therapy specifically for burnout.2 It is also the largest real-world cohort by sample size.
The patient population included 395 adults who completed all six sessions and all four MBI-GS assessments. These individuals were drawn from 1,642 who met the baseline burnout threshold. The mean age was 42.1 years, 54.2% were female, and patients used either sublingual or subcutaneous racemic ketamine.
Patients completed six guided sessions over approximately four to six weeks. The protocol components are detailed in the program section below. Outcomes were measured using the MBI-GS (Maslach Burnout Inventory, General Survey), a validated workplace instrument with three subscales. Response was defined as a 1-point or greater improvement on a subscale.
The research is a real-world retrospective cohort analysis, not a randomized controlled trial. Outcomes are observed rather than proven caused. The MBI-GS measures occupational burnout, meaning every outcome number reflects working adults measured on a standardized occupational measure.
| Parameter | Detail |
|---|---|
| Design | Real-world retrospective cohort |
| Total meeting threshold | 1,642 |
| Completers (denominator) | 395 (24.1%) |
| Instrument | MBI-GS (Exhaustion, Cynicism, Professional Efficacy) |
| Eligibility threshold | Exhaustion ≥ 4.8 AND (Cynicism ≥ 3.8 OR Professional Efficacy ≤ 4.3) |
| Treatment | Racemic ketamine, sublingual or subcutaneous |
| Session count | 6 sessions over 4 to 6 weeks |
| Response definition | ≥1-point subscale improvement |
Ketamine for Burnout: Overall Outcomes From Mindbloom's Analysis
Among 395 adults who completed treatment, 69.6% improved by 1 point or more on at least one burnout subscale. Furthermore, 46.1% improved on two or more subscales, and 14.9% improved on all three.2
The table below shows response rates by measure.
| Dimension | % Who Responded | Average Change |
|---|---|---|
| Exhaustion | 55.4% | 27% reduction in symptom severity |
| Cynicism | 48.9% | 22% reduction in symptom severity |
| Professional Efficacy | 26.3% | 7% increase in sense of efficacy |
| At least one dimension | 69.6% | Not applicable |
By post-session six, 59.5% of patients fell below the burnout threshold.
Of the 71 patients with the most severe burnout profile at baseline, 76.1% no longer met that classification after treatment. Additionally, 32.4% moved all the way to the Engaged state. The severe profile resolution is the primary outcome and the strongest single finding in the data.
By the end of treatment, nearly half of patients (49%) were classified as Engaged, up from about 17% at the start. Fully 44% of patients who were burned out at the start reached a fully non-burned-out state.
As exhaustion and cynicism resolved, some patients found themselves no longer depleted but still rebuilding their sense of effectiveness. The Ineffective share rose from 5.6% to 17.2%, which represents a stage of rebuilding rather than a failure. Professional efficacy is the slowest-moving dimension and the one most likely to require behavioral change alongside the biological shift.
Relief did not require finishing the full course to begin. Meaningful improvement started within the first two sessions, about two weeks in. For people who have been running on empty for months, that early movement matters. By the first follow-up assessment, the effect on exhaustion was already medium-sized and cynicism showed a small-to-medium effect.
From there the gains kept building rather than leveling off: exhaustion grew to a large effect by the sixth session and cynicism to medium-large, with no plateau.
The table below shows how each burnout subscale changed across the treatment course, a trajectory of deepening improvement.
| Session | Exhaustion | Cynicism | Professional Efficacy |
|---|---|---|---|
| Baseline | 5.57 | 4.89 | 3.78 |
| Post-Session 2 | 4.95 (11% reduction) | 4.38 (10% reduction) | 3.98 (5% increase) |
| Post-Session 4 | 4.32 (22% reduction) | 3.98 (19% reduction) | 4.06 (7% increase) |
| Post-Session 6 | 4.09 (27% reduction) | 3.82 (22% reduction) | 4.03 (7% increase) |
Side effects were low and stable, occurring at 4.3% at session two, 3.5% at session four, and 4.1% at session six. No serious side effects were reported in the cohort. In Mindbloom's broader published safety data, serious adverse events occurred in fewer than 0.1% of sessions.3
How Ketamine Affected Each Burnout Dimension
Exhaustion, cynicism, and professional efficacy each responded to treatment differently, and the differences matter.
Exhaustion: The Core of Burnout and the Largest Result
No other dimension hits as hard as exhaustion, and no other burnout dimension moved as much in the data. Among completers in Mindbloom's analysis, 55.4% met the response threshold, with an average reduction in symptom severity of 27%.2 The group mean fell below the 4.8 entry threshold by the end of treatment. Exhaustion is the component people feel most acutely, and it moved the most.
Cynicism: The Burnout-Specific Signal
Cynicism is the marker that makes burnout distinct from depression, and it is the one that surprises people most when it lifts. Cynicism in burnout is not just negativity. It is going through the motions at work or the emotional withdrawal from a role you used to care about. In caregiving or parenting, it is the guilt of pulling back from people you love because you have nothing left to give.
When cynicism lifts, people do not just feel less tired; they start caring again. The return of care signals something beyond depression lifting. In Mindbloom's published outcomes, 48.9% met the response threshold, with an average reduction in symptom severity of 22%.2 Improvement continued to build through all six sessions with no plateau.
Professional Efficacy: The Slowest-Moving Dimension
Professional efficacy moved in the right direction, but not at the same magnitude as exhaustion and cynicism. 26.3% met the response threshold — a smaller signal, but a real one: the confidence interval on that response rate does not overlap with exhaustion or cynicism, which means the smaller signal is real, not noise.
The average improvement was a 7% increase in the sense of efficacy, with gains concentrated in how people felt about their accomplishments and contribution. The metric plateaued by session four.
Professional efficacy is the dimension most closely tied to how someone feels about their performance in a specific role — and that kind of confidence tends to rebuild gradually, through experience and behavioral change, not biology alone. The data is consistent with that: the biological reset that ketamine may provide creates the conditions for that rebuilding to happen, but the rebuilding itself takes time. That is not a limitation of the treatment; it is a realistic picture of how this dimension works.
Is Burnout the Same as Depression?
Burnout and depression frequently co-occur and overlap on the measurement instrument. The MBI-GS was not designed to isolate burnout-specific change from depression-related change, and the preprint does not claim to have done so.
The strongest evidence that something beyond depression lifting was happening is the cynicism result. Cynicism, which is emotional distancing and detachment toward a role, is not a core depression symptom. Its 22% reduction and 48.9% response rate represent the cleanest signal of burnout-specific relief in the data.
Where depression treatments primarily target mood and anhedonia, the 22% reduction in cynicism suggests the treatment reached the role-specific erosion that defines burnout.
The preprint flags a PHQ-9 paired analysis as the next step. Future research will help isolate burnout-specific change from depression-related change.
How Ketamine May Target the Neurobiology of Burnout
Ketamine is an NMDA receptor antagonist that is thought to produce rapid increases in neuroplasticity. Its mechanism may map onto what chronic burnout does to the brain. The chronic stress biology described earlier, HPA-axis dysregulation, altered glutamate signaling, and reduced BDNF, maps onto ketamine's known mechanism, as well as default mode network hyperconnectivity.
Ketamine is thought to temporarily modulate NMDA receptors, triggering a downstream surge in glutamate release. The surge may activate AMPA receptors and lead to rapid BDNF release and synaptogenesis. Researchers believe the process helps reverse the synaptic changes associated with chronic stress, potentially restoring cognitive flexibility, emotional regulation, and prefrontal function.4
Chronic stress biology, including HPA-axis dysregulation and reduced BDNF, is what burnout shares with other stress syndromes. The shared biology may help explain why exhaustion and cynicism, the stress-driven components, moved the most. Professional efficacy, which is more behavioral and role-specific, showed the smallest effect. The smaller effect is consistent with the idea that neuroplasticity creates the conditions for change, but behavioral change in a role requires more than a biological shift alone.5
Research suggests ketamine may reduce default mode network hyperconnectivity during sessions. The default mode network is associated with rumination and looping, preoccupied thinking that characterizes the cognitive exhaustion of burnout.6
What the Mindbloom Burnout Program Looks Like
Mindbloom's burnout program is a defined at-home treatment framework that includes medical evaluation, guide coaching, integration support, and ongoing provider oversight. These outcomes are specific to the Mindbloom protocol and are not generalizable to ketamine therapy as a category. Outcomes from other providers, delivery routes, or care models may differ.
The program includes several core components:
- Comprehensive medical evaluation: A personalized treatment plan based on a thorough assessment.
- At-home sessions: A peer treatment monitor is required to be present throughout every session.
- App-guided preparation and integration: You receive guided preparation content before each session and reflection support after.
- One-on-one guide coaching sessions: You get dedicated support for applying insights to daily life.
- Unlimited guide messaging: You have between-session access for questions and ongoing support.
- Group Integration Circles: You can engage in community-based processing with other clients.
- Ongoing provider oversight and dosage support: You receive continuous medical monitoring throughout the program.
Integration is the process of reflecting on, making sense of, and applying insights from ketamine sessions to daily life. For burnout specifically, integration helps people identify the patterns, demands, boundaries, and roles that drove the chronic stress in the first place. The neuroplastic window that ketamine opens is where the behavioral and psychological work happens.
These outcomes came from at-home ketamine therapy, not a specialty clinic.
Who This May Be Right For
The treatment may be appropriate for people experiencing sustained exhaustion, cynicism or detachment, and reduced efficacy in a demanding role. The population was working adults measured on a validated workplace instrument. If you are experiencing the same pattern in a caregiving or parenting role, the underlying biology is similar, but these specific outcomes reflect working adults.
Results held broadly across age, sex, and route of administration. No subgroup was distinguishable from the cohort rate. The burnout-named pathway did not outperform other pathways on any subscale.
A licensed provider evaluates each person individually to determine eligibility. Eligibility is determined through a clinical assessment, and conditions such as uncontrolled hypertension, active psychotic disorders, and active substance use disorders may preclude treatment or require additional evaluation. Ketamine is FDA-approved as an anesthetic. Its use for burnout is prescribed off-label by licensed providers at their discretion.
Conclusion
Mindbloom's preprint provides the first published real-world outcomes data for ketamine-assisted therapy specifically for burnout. The data shows a 27% reduction in exhaustion and 22% reduction in cynicism, a modest 7% gain in professional efficacy, and the importance of completing the full course. The research is a preprint, outcomes are observational, and individual results may vary.
Important Safety Information
Ketamine is not FDA-approved for burnout, PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information
Off-Label Use Disclosure
Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.
Frequently asked questions
What did Mindbloom's burnout data find?
Among 395 adults who completed Mindbloom's at-home ketamine therapy treatment, 69.6% improved on at least one burnout subscale, and 76.1% of those with the most severe burnout profile no longer met that classification.
Is ketamine approved for burnout?
Ketamine is FDA-approved as an anesthetic. Its use for burnout-related symptoms is off-label prescribing by licensed medical professionals based on their judgment, a common practice across psychiatry.
How quickly does ketamine therapy work for burnout?
In Mindbloom's analysis, meaningful improvement on exhaustion and cynicism began within the first two sessions, which is approximately two weeks. Gains continued to deepen through all six sessions with no plateau.
They are related but not identical. Burnout is role-rooted and defined by cynicism and detachment toward a specific role, while depression is a pervasive, global lowering of mood. They co-occur frequently, but cynicism is the burnout-specific signal.
They are related but not identical. Burnout is role-rooted and defined by cynicism and detachment toward a specific role, while depression is a pervasive, global lowering of mood. They co-occur frequently, but cynicism is the burnout-specific signal.
Does this work for caregiver or parental burnout?
The published data show burnout symptom improvement in working adults, and similar stress biology suggests the approach may be relevant to caregiving and parental burnout, although those populations have not yet been studied directly.
What does no longer classified as burned out mean?
It means the person's scores on the MBI-GS fell below the operational threshold used to classify someone as burned out. It is not a medical diagnosis being lifted, as burnout is classified as an occupational phenomenon rather than a medical condition.
How long does treatment take?
Mindbloom's burnout program is six guided sessions delivered over approximately four to six weeks. Treatment frequency is personalized based on individual needs and provider guidance.
Mindbloom Treatment
Some sort of description will go here about what Mindbloom ketamine therapy actually does and what it promises.
Authors
